NCBI Taxonomy: 507393

Combretum caffrum (ncbi_taxid: 507393)

found 92 associated metabolites at species taxonomy rank level.

Ancestor: Combretum

Child Taxonomies: none taxonomy data.

Acacetin

4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-

C16H12O5 (284.0684702)


5,7-dihydroxy-4-methoxyflavone is a monomethoxyflavone that is the 4-methyl ether derivative of apigenin. It has a role as an anticonvulsant and a plant metabolite. It is a dihydroxyflavone and a monomethoxyflavone. It is functionally related to an apigenin. It is a conjugate acid of a 5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate. Acacetin is a natural product found in Verbascum lychnitis, Odontites viscosus, and other organisms with data available. Acacetin (5,7-Dihydroxy-4'-methoxyflavone) is an orally active flavonoid derived from Dendranthema morifolium. Acacetin docks in the ATP binding pocket of PI3Kγ. Acacetin causes cell cycle arrest and induces apoptosis and autophagy in cancer cells. Acacetin has potent anti-cancer and anti-inflammatory activity and has the potential for pain-related diseases research[1][2]. Acacetin (5,7-Dihydroxy-4'-methoxyflavone) is an orally active flavonoid derived from Dendranthema morifolium. Acacetin docks in the ATP binding pocket of PI3Kγ. Acacetin causes cell cycle arrest and induces apoptosis and autophagy in cancer cells. Acacetin has potent anti-cancer and anti-inflammatory activity and has the potential for pain-related diseases research[1][2].

   

Combretum caffrum

3,3,4-Tri-O-methylellagic acid; 3,3,4-Trimethoxyellagic acid; 3,4,3-Tri-O-methylellagic acid; Ellagic acid 3,3,4-trimethyl ether

C17H12O8 (344.0532152)


3,4,3-Tri-O-methylellagic acid is a tannin. 2,3,8-Tri-O-methylellagic acid is a natural product found in Lagerstroemia speciosa, Cercidiphyllum japonicum, and other organisms with data available.

   

Combretastatin_A-4

phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate)

C18H20O5 (316.13106700000003)


Combretastatin A4 is a stilbenoid. Combretastatin A4 is a natural product found in Combretum caffrum with data available. Combretastatin A-4 is an inhibitor of microtubule polymerization derived from the South African willow bush which causes mitotic arrest and selectively targets and reduces or destroys existing blood vessels, causing decreased tumor blood supply. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D000970 - Antineoplastic Agents Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.

   

Combretastatin

3-Hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)benzeneethanol

C18H22O6 (334.1416312)


   

Combretastatin A-1

3-methoxy-6-[2-(3,4,5-trimethoxyphenyl)ethenyl]benzene-1,2-diol

C18H20O6 (332.125982)


   

5-[2-(3-Hydroxy-4,5-dimethoxyphenyl)ethyl]-2-methoxyphenol

5-[2-(3-Hydroxy-4,5-dimethoxyphenyl)ethyl]-2-methoxyphenol

C17H20O5 (304.13106700000003)


   

Combretastatin

3,7-Dihydroxy-3,4,45-tetramethoxybibenzyl

C18H22O6 (334.1416312)


D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

Acacetin

4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-

C16H12O5 (284.0684702)


5,7-dihydroxy-4-methoxyflavone is a monomethoxyflavone that is the 4-methyl ether derivative of apigenin. It has a role as an anticonvulsant and a plant metabolite. It is a dihydroxyflavone and a monomethoxyflavone. It is functionally related to an apigenin. It is a conjugate acid of a 5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate. Acacetin is a natural product found in Verbascum lychnitis, Odontites viscosus, and other organisms with data available. A monomethoxyflavone that is the 4-methyl ether derivative of apigenin. 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one, also known as 4-methoxy-5,7-dihydroxyflavone or acacetin, is a member of the class of compounds known as 4-o-methylated flavonoids. 4-o-methylated flavonoids are flavonoids with methoxy groups attached to the C4 atom of the flavonoid backbone. Thus, 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one is considered to be a flavonoid lipid molecule. 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one can be synthesized from apigenin. 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one is also a parent compound for other transformation products, including but not limited to, acacetin-7-O-beta-D-galactopyranoside, acacetin-8-C-neohesperidoside, and isoginkgetin. 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one can be found in ginkgo nuts, orange mint, and winter savory, which makes 5,7-dihydroxy-2-(4-methoxyphenyl)-4h-chromen-4-one a potential biomarker for the consumption of these food products. Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.223 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.225 Acacetin (5,7-Dihydroxy-4'-methoxyflavone) is an orally active flavonoid derived from Dendranthema morifolium. Acacetin docks in the ATP binding pocket of PI3Kγ. Acacetin causes cell cycle arrest and induces apoptosis and autophagy in cancer cells. Acacetin has potent anti-cancer and anti-inflammatory activity and has the potential for pain-related diseases research[1][2]. Acacetin (5,7-Dihydroxy-4'-methoxyflavone) is an orally active flavonoid derived from Dendranthema morifolium. Acacetin docks in the ATP binding pocket of PI3Kγ. Acacetin causes cell cycle arrest and induces apoptosis and autophagy in cancer cells. Acacetin has potent anti-cancer and anti-inflammatory activity and has the potential for pain-related diseases research[1][2].

   
   

3,4,6,7-TETRAMETHOXY-9,10-DIHYDROPHENANTHREN-2-OL

3,4,6,7-TETRAMETHOXY-9,10-DIHYDROPHENANTHREN-2-OL

C18H20O5 (316.13106700000003)


   
   

Combrestatin A4

2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol

C18H20O5 (316.13106700000003)


Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.

   

5-[(1e)-2-(3,4-dimethoxyphenyl)ethenyl]-2,3-dimethoxyphenol

5-[(1e)-2-(3,4-dimethoxyphenyl)ethenyl]-2,3-dimethoxyphenol

C18H20O5 (316.13106700000003)


   

3,5,6,7-tetramethoxyphenanthren-2-ol

3,5,6,7-tetramethoxyphenanthren-2-ol

C18H18O5 (314.1154178)


   

5-[(2s)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol

5-[(2s)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol

C18H22O6 (334.1416312)


   

2-methoxy-5-[(1e)-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)ethenyl]phenol

2-methoxy-5-[(1e)-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)ethenyl]phenol

C17H16O5 (300.0997686)


   

4-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol

4-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol

C17H20O4 (288.13615200000004)


   

5,6,7-trimethoxy-9,10-dihydrophenanthrene-2,3-diol

5,6,7-trimethoxy-9,10-dihydrophenanthrene-2,3-diol

C17H18O5 (302.1154178)


   

5-[(1z)-2-(3,4-dimethoxyphenyl)ethenyl]-2,3-dimethoxyphenol

5-[(1z)-2-(3,4-dimethoxyphenyl)ethenyl]-2,3-dimethoxyphenol

C18H20O5 (316.13106700000003)


   

3,5,6,7-tetramethoxy-9,10-dihydrophenanthren-2-ol

3,5,6,7-tetramethoxy-9,10-dihydrophenanthren-2-ol

C18H20O5 (316.13106700000003)


   

(2r,4r)-13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

(2r,4r)-13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

C18H16O5 (312.0997686)


   

3,4,6-trimethoxy-9,10-dihydrophenanthrene-2,7-diol

3,4,6-trimethoxy-9,10-dihydrophenanthrene-2,7-diol

C17H18O5 (302.1154178)


   

2-methoxy-5-[(1z)-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)ethenyl]phenol

2-methoxy-5-[(1z)-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)ethenyl]phenol

C17H16O5 (300.0997686)


   

13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

C18H16O5 (312.0997686)


   

3-methoxy-6-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]benzene-1,2-diol

3-methoxy-6-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]benzene-1,2-diol

C18H20O6 (332.125982)


   

5-[2-(3,5-dimethoxyphenyl)ethyl]-2-methoxyphenol

5-[2-(3,5-dimethoxyphenyl)ethyl]-2-methoxyphenol

C17H20O4 (288.13615200000004)


   

4-[2-(3,5-dimethoxyphenyl)ethyl]benzene-1,2-diol

4-[2-(3,5-dimethoxyphenyl)ethyl]benzene-1,2-diol

C16H18O4 (274.1205028)


   

4-[2-(3,4,5-trimethoxyphenyl)ethyl]benzene-1,2-diol

4-[2-(3,4,5-trimethoxyphenyl)ethyl]benzene-1,2-diol

C17H20O5 (304.13106700000003)


   

(13z)-4-hydroxy-2,11-dioxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,13,15,18-heptaen-10-one

(13z)-4-hydroxy-2,11-dioxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,13,15,18-heptaen-10-one

C18H16O4 (296.1048536)


   

5-[(1z)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]-2,3-dimethoxyphenol

5-[(1z)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]-2,3-dimethoxyphenol

C17H18O5 (302.1154178)


   

5-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-2,3-dimethoxyphenol

5-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-2,3-dimethoxyphenol

C17H20O5 (304.13106700000003)


   

(2s,4r)-13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

(2s,4r)-13-hydroxy-3,6,15-trioxatetracyclo[14.2.2.1¹⁰,¹⁴.0²,⁴]henicosa-1(18),10,12,14(21),16,19-hexaen-7-one

C18H16O5 (312.0997686)